Aller au contenu principal

Anti infectives drug development Webinar 21-22 April 2021

Published by Maxime F. - 01 April 2021


Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance.

Image de la news